|
|
|
Insider
Information: |
Gray Mary Ann |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
270,896 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,906,269 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
270,896 |
|
|
Total
Value |
$3,906,269 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mabvax Therapeutics Holdings Inc |
MBVX |
Director |
2005-03-16 |
5,000 |
2005-03-16 |
0 |
Premium* |
|
GTC Biotherapeutics Inc |
GTCB |
Director |
2007-12-17 |
11,000 |
|
0 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2016-06-07 |
149,476 |
2013-08-26 |
0 |
Premium* |
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2016-04-05 |
0 |
Premium* |
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
39,167 |
|
0 |
Premium* |
|
Senomyx Inc |
SNMX |
Director |
2018-11-02 |
0 |
2017-03-24 |
0 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2022-03-07 |
12,356 |
2019-03-04 |
0 |
Premium* |
|
Bioatla, Inc. |
BCAB |
|
2024-06-13 |
53,897 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MBVX |
Mabvax Therapeutics Holdi... |
Director |
|
2005-03-16 |
4 |
B |
$15.47 |
$77,780 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2014-12-15 |
4 |
OE |
$7.67 |
$115,780 |
D/D |
12,250 |
12,250 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2013-08-26 |
4 |
OE |
$7.67 |
$123,250 |
D/D |
15,000 |
15,000 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2015-01-13 |
4 |
AS |
$35.00 |
$148,750 |
D/D |
(4,250) |
0 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2016-06-07 |
4 |
OE |
$9.04 |
$150,398 |
D/D |
16,637 |
149,476 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2016-04-07 |
4 |
OE |
$1.30 |
$176,600 |
D/D |
132,839 |
132,839 |
0 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2018-08-14 |
4 |
D |
$11.50 |
$186,806 |
D/D |
(16,244) |
0 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2013-08-26 |
4 |
AS |
$20.62 |
$310,211 |
D/D |
(15,000) |
0 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2014-12-15 |
4 |
AS |
$31.74 |
$388,815 |
D/D |
(12,250) |
0 |
0 |
- |
|
34 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|